XML 83 R49.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes (Tables)
12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Income Taxes (Tables) [Line Items]    
Schedule of Income Tax Expenses The Company’s income tax expenses for years ended June 30, 2024 and 2023 are as follows:
   For the Years Ended
June 30,
 
   2024   2023 
Federal        
Current  $12,690   $13,502 
Deferred   

    

 
State          
Current   7,138    735 
Deferred   

    

 
Total provision for income taxes   19,828    14,237 
 
Schedule of Effective Tax Rate Reconciliations between the expected federal income tax rates using 21% for the years ended June 30, 2024 and 2023 to the Company’s effective tax rate are as follows:
   For the Years Ended
June 30,
 
   2024   2023 
         
Federal statutory tax rate   21.0%   21.0%
State statutory tax rate, net of deduction on federal tax return   4.2%   5.8%
Permanent difference   (1.7)%   1.3%
Others   0.9%   
-
%
Change in valuation allowance   (25.0)%   (8.4)%
Effective tax rate   (0.6)%   19.7%

 

 
Schedule of Deferred Tax The Company’s deferred tax accounts are comprised of the following as of:
   June 30,
2024
   June 30,
2023
 
Deferred tax assets        
Net operating loss        
Federal  $1,758,686    1,086,843 
State   212,385    34,863 
Capitalized R&D expense   70,451    55,540 
Accrued warranty expense   7,382    
-
 
Lease liabilities   109,903    
-
 
Less:  valuation allowance   (2,034,319)   (1,172,171)
Total deferred tax assets   124,488    5,075 
           
Deferred tax liabilities:          
Depreciation of property and equipment  $(14,371)  $(5,075)
Right of use assets   (110,117)   
-
 
Total deferred tax liability   (124,488)   (5,075)
Total deferred tax accounts, net  $
-
   $
-
 
 
Schedule of Taxes Payable The Company’s taxes payable consist of the following:
   June 30,   June 30, 
   2024   2023 
Income taxes payable  $
-
   $15,842 
 
Acri Capital Acquisition Corporation [Member]    
Income Taxes (Tables) [Line Items]    
Schedule of Income Tax Expenses   The income tax provision (benefit) consists of the following for the year ended December 31, 2023 and the period from January 7, 2022 (inception) through December 31, 2022:
   For the
year ended
December 31,
2023
   For the
Period
from
January 7,
2022 (inception)
through
December 31,
2022
 
Current        
Federal  $458,077   $173,680 
State   
    
 
Deferred          
Federal   (162,336)   (67,458)
State        
 
Valuation allowance   135,678    128,052 
Income tax provision   431,419   $234,274 

 

Schedule of Effective Tax Rate   A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:
   For the
year ended
December 31,
2023
   For the Period
from January 7,
2022 (inception)
through
December 31,
2022
 
U.S. statutory rate   21.0%   21.0%
Change in valuation allowance   10.3%   28.4%
Permanent difference   1.4%   2.5%
Effective tax rate   32.7%   51.9%
Schedule of Deferred Tax   The Company’s net deferred tax assets were as follows as of:
   December 31,
2023
   December 31,
2022
 
Deferred tax assets:        
Start-up costs  $263,730   $128,052 
Valuation allowance   (263,730)   (128,052)
Total deferred tax assets   
    
 
Accrued interest income   (33,937)   (60,594)
Deferred tax liability, net  $(33,937)  $(60,594)